Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | +0.28% | +2.01% | +561.08% |
01:59pm | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
02/05 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+561.08% | 193M | |
+4.54% | 111B | |
+11.63% | 105B | |
-12.94% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.07% | 16.96B | |
+3.50% | 13.7B | |
+37.60% | 12.45B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Says It Has Funds to Continue Operations Into H2 2025